<p>We conducted a hospital-based cross-sectional study between September 2022 and February 2023. We collected 239 clinical samples from which we isolated and identified K. pneumoniae using standard microbiological methods. We conducted the antimicrobial susceptibility testing for phenotypic detection of carbapenemase production in the isolates using a disc diffusion method. We detected the carbapenemase resistance genes blaKPC and blaOXA in using the polymerase chain reaction.</p>